Breaking News, Promotions & Moves

Alexis Peyroles Departs OSE Immunotherapeutics as CEO

A search for a new CEO has been launched.

Author Image

By: Charlie Sternberg

Associate Editor

OSE Immunotherapeutics SA has announced the departure of Alexis Peyroles as chief executive officer. Dominique Costantini, current chairwoman of OSE Immunotherapeutics’ Board of Directors, and previously CEO from 2012 to 2018, has been appointed interim chief executive officer, effective immediately. A search for a new CEO has been launched with the assistance of a leading executive search firm.   Peyroles is stepping down for health reasons and he remains committed to OSE’s success. He will c...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters